Stryker Corporation (SYK)
Stryker to announce financial results for its fourth quarter and full year 2025
Stryker to announce financial results for its fourth quarter and full year 2025
Ensysce Biosciences Issues Annual Shareholder Letter
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Lineage Cell Therapeutics Issues Letter to Stockholders
Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel
Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference
Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference
AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism
DocGo Announces Upcoming Participation at 28th Annual Needham Growth Conference